J. El-Sheikha
Clinical outcomes and quality of life 5 years after a randomized trial of concomitant or sequential phlebectomy following endovenous laser ablation for varicose veins
El-Sheikha, J.; Nandhra, S.; Carradice, D.; Wallace, T.; Samuel, N.; Smith, George; Chetter, I. C.
Authors
S. Nandhra
Professor Daniel Carradice D.Carradice@hull.ac.uk
Senior Lecturer in Vascular and Endovascular Surgery
T. Wallace
N. Samuel
Mr George Smith George.Smith@hull.ac.uk
Senior Lecturer
Professor Ian Chetter I.Chetter@hull.ac.uk
Professor of Vascular Surgery
Abstract
BackgroundEndovenous laser ablation (EVLA) is a popular treatment for superficial venous insufficiency. Debate continues regarding the optimal management of symptomatic varicose tributaries following ablation of the main saphenous trunk. This randomized trial compared the 5-year outcomes of endovenous laser therapy with ambulatory phlebectomy (EVLTAP) with concomitant ambulatory phlebectomy, and EVLA alone with sequential treatment if required following a delay of at least 6 weeks.MethodsPatients undergoing EVLA for great saphenous vein insufficiency were randomized to receive EVLTAP or EVLA alone with sequential phlebectomy, if required. Outcomes included disease-specific quality of life (QoL) (Aberdeen Varicose Vein Questionnaire; AVVQ), requirement for secondary procedures, clinical severity (Venous Clinical Severity Score; VCSS), residual and recurrent varicose tributaries, and generic QoL. Patients were followed up for 5 years.ResultsFifty patients were randomized equally into two parallel groups. The EVLTAP group had lower VCSS scores at 12 weeks (median 0 (i.q.r. 0-1) versus 2 (0-2); P <0·001), and lower AVVQ scores at 6 weeks (median 7·9 (i.q.r. 4·1-10·7) versus 13·5 (10·9-18·1); P < 0·001) and 12 weeks (2·0 (0·4-7·7) versus 9·6 (2·2-13·8); P = 0·015). VCSS and AVVQ scores were equivalent by 1 year, but only after 16 of 24 patients in the EVLA group, compared with one of 25 in the EVLTAP group (P < 0·001), had received a secondary intervention. From 1 to 5 years both groups had equivalent outcomes.ConclusionEVLA with either concomitant or sequential management of tributaries is acceptable treatment for symptomatic varicose veins, with both treatments achieving excellent results at 5 years. Concomitant treatment of varicosities is associated with optimal improvement in both clinical disease severity and QoL.
Citation
El-Sheikha, J., Nandhra, S., Carradice, D., Wallace, T., Samuel, N., Smith, G., & Chetter, I. C. (2014). Clinical outcomes and quality of life 5 years after a randomized trial of concomitant or sequential phlebectomy following endovenous laser ablation for varicose veins. British journal of surgery, 101(9), 1093-1097. https://doi.org/10.1002/bjs.9565
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 17, 2014 |
Online Publication Date | Jun 11, 2014 |
Publication Date | 2014-08 |
Journal | British Journal of Surgery |
Print ISSN | 0007-1323 |
Electronic ISSN | 1365-2168 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 101 |
Issue | 9 |
Pages | 1093-1097 |
DOI | https://doi.org/10.1002/bjs.9565 |
Keywords | Surgery |
Public URL | https://hull-repository.worktribe.com/output/432658 |
You might also like
Endovenous thermal ablation for healing venous ulcers and preventing recurrence.
(2013)
Journal Article
Evolution of an endovenous laser ablation practice for varicose veins
(2012)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search